This research study is being conducted to test the effects of two drugs on blood lipids
(cholesterol and triglycerides) and blood sugar (glucose) levels in patients with diabetes or
"pre-diabetes" (both of which have a condition called "insulin-resistance"). These products
are Niaspan (extended release nicotinic acid) and Omacor (omega-3 acid ethyl esters). We
hypothesize that the combination of Niaspan and Omacor will reduce serum triglyceride levels,
increase HDL-cholesterol levels and do so without altering glucose levels.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) University of South Dakota
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)